Cart
sales@molnova.com
Flutamide Related Compound B
CAS No. 393-12-4
Flutamide Related Compound B( —— )
Catalog No. M14353 CAS No. 393-12-4
Used as pharmaceutical intermediates.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | 45 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFlutamide Related Compound B
-
NoteResearch use only, not for human use.
-
Brief DescriptionUsed as pharmaceutical intermediates.
-
DescriptionUsed as pharmaceutical intermediates.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number393-12-4
-
Formula Weight248.16
-
Molecular FormulaC9H7F3N2O3
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESCC(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Braco-19 trihydrochl...
BRACO19 is a telomerase inhibitor. It also stabilizes G-quadruplexes, targeting telomeric G-quadruplexes.
-
18α-Glycylrrhizin
18α-Glycyrrhizic acid is a derivate of Glycyrrhizic acid. 18α-Glycyrrhizic acid has weak antihepatotoxic anti-inflammatory activities.
-
VUT-MK142
VUT-MK142 is a new cardiomyogenic small molecule promoting the differentiation of pre-cardiac mesoderm into cardiomyocytes,which may be useful to differentiate stem cells into cardiomyocytes for cardiac repair.VUT-MK142 was identified as the most promising candidate with respect to cardiomyogenic activity.?
